Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) saw a significant decrease in short interest in November. As of November 30th, there was short interest totalling 593,500 shares, a decrease of 10.8% from the November 15th total of 665,100 shares. Approximately 1.8% of the company’s shares are short sold. Based on an average trading volume […]
Related Keywords
, Virtu Financial , Renaissance Technologies , Nasdaq , Millennium Management , Elevation Oncology Inc , Blackrock Inc , Annandale Capital , Elevation Oncology , Get Free Report , Oncology Stock Down , Elevation Oncology Daily , Nasdaq Elev , Belev , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.